Wellgistics Health, Inc. (WGRX)
NASDAQ: WGRX · Real-Time Price · USD
4.570
+0.110 (2.47%)
May 5, 2025, 4:00 PM EDT - Market closed
Wellgistics Health Revenue
In the year 2024, Wellgistics Health had annual revenue of $18.13M. Wellgistics Health had revenue of $12.41M in the quarter ending December 31, 2024.
Revenue (ttm)
$18.13M
Revenue Growth
n/a
P/S Ratio
11.91
Revenue / Employee
$584,801
Employees
31
Market Cap
238.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.13M | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionWGRX News
- 5 days ago - Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion with Over 350 New Pharmacies Added to Its Nationwide Network - Accesswire
- 11 days ago - Wellgistics Names Mark DiSiena as New CFO - Accesswire
- 20 days ago - CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price - Accesswire
- 25 days ago - Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue - Accesswire
- 6 weeks ago - Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models - GlobeNewsWire
- 2 months ago - Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure - GlobeNewsWire
- 2 months ago - Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND™ - GlobeNewsWire
- 2 months ago - Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market - GlobeNewsWire